Girl with leukemia in remission after new treatment

12/10/2012 | New York Times (tiered subscription model), The

A girl with acute lymphoblastic leukemia experienced remission after being treated with an experimental therapy that involved using a disabled form of the virus that causes AIDS to reprogram her immune system genetically to fight cancer cells. The girl is considered the first child to undergo the treatment, and some experts said could someday serve in place of bone marrow transplants. Novartis has expressed interest in the treatment and has pledged $20 million for the establishment of a research center at the University of Pennsylvania.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC